Free Trial
NASDAQ:GRI

GRI Bio (GRI) Stock Price, News & Analysis

GRI Bio logo
$1.26 +0.01 (+0.80%)
As of 04:00 PM Eastern

About GRI Bio Stock (NASDAQ:GRI)

Key Stats

Today's Range
$1.23
$1.28
50-Day Range
$1.25
$2.14
52-Week Range
$1.10
$30.43
Volume
41,696 shs
Average Volume
269,579 shs
Market Capitalization
$3.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
Consensus Rating
Buy

Company Overview

GRI Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

GRI MarketRank™: 

GRI Bio scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GRI Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GRI Bio has only been the subject of 2 research reports in the past 90 days.

  • Read more about GRI Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for GRI Bio are expected to grow in the coming year, from ($3.04) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GRI Bio is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GRI Bio is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GRI Bio has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about GRI Bio's valuation and earnings.
  • Percentage of Shares Shorted

    5.16% of the float of GRI Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    GRI Bio has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GRI Bio has recently increased by 121.48%, indicating that investor sentiment is decreasing significantly.
  • Percentage of Shares Shorted

    5.16% of the float of GRI Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    GRI Bio has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GRI Bio has recently increased by 121.48%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    GRI Bio has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.
  • Search Interest

    Only 1 people have searched for GRI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added GRI Bio to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GRI Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.87% of the stock of GRI Bio is held by insiders.

  • Percentage Held by Institutions

    Only 33.95% of the stock of GRI Bio is held by institutions.

  • Read more about GRI Bio's insider trading history.
Receive GRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GRI Bio and its competitors with MarketBeat's FREE daily newsletter.

GRI Stock News Headlines

Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines

GRI Stock Analysis - Frequently Asked Questions

GRI Bio's stock was trading at $14.0828 at the beginning of 2025. Since then, GRI shares have decreased by 91.0% and is now trading at $1.27.

GRI Bio, Inc. (NASDAQ:GRI) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($5.80) EPS for the quarter, missing analysts' consensus estimates of ($4.08) by $1.72.

Shares of GRI Bio reverse split on the morning of Monday, February 24th 2025.The 1-17 reverse split was announced on Wednesday, February 19th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Shares of GRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GRI Bio investors own include SoFi Technologies (SOFI), NuCana (NCNA), Caribou Biosciences (CRBU), Cardio Diagnostics (CDIO), Intrusion (INTZ), Lonestar Resources US (LONE) and Children's Place (PLCE).

Company Calendar

Last Earnings
5/15/2025
Today
8/08/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GRI
CIK
1824293
Fax
N/A
Employees
1
Year Founded
N/A

Price Target and Rating

High Price Target
$34.00
Low Price Target
$10.00
Potential Upside/Downside
+1,632.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($11.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.21 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-275.15%
Return on Assets
-168.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.41
Quick Ratio
1.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.68 per share
Price / Book
0.17

Miscellaneous

Outstanding Shares
2,497,000
Free Float
2,475,000
Market Cap
$3.17 million
Optionable
Not Optionable
Beta
-1.61

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GRI) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners